“Suppression of Medulloblastoma Cell Migration by clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting”.
- Niklison Chirou, M. (Speaker)
Activity: Academic conferences and events (excluding conference publications) › Conference presentation / attendance